HOME >> BIOLOGY >> NEWS
Immune response depends on key molecule: Research

In a new study published in the April 1, 2003 issue of Genes and Development, scientists at University Health Network's Advanced Medical Discovery Institute (AMDI)/Ontario Cancer Institute (OCI) have shown that a molecule called caspase-8 plays a key role in the immune system response, by controlling how T-cells are activated to respond to infections.

T-cells are white blood cells that recognize and fight off viruses and bacteria. When T-cells encounter these foreign invaders they build up a T-cell "army" by multiplying themselves many thousand-fold in process known as activation. Once their job is complete, T-cells are eliminated in a process known as apoptosis. While caspase-8 is largely recognized as a critical factor in this elimination process, this study produced a new finding: caspase-8 is also essential for the activation of T-cells at the start of the immune response.

"This research has helped us better understand how caspase-8 activates the immune system response by triggering T-cells to proliferate. When caspase-8 is inhibited, the immune response is significantly decreased," explains Dr. Razqallah Hakem, principal investigator AMDI/OCI and Assistant Professor in Medical Biophysics at the University of Toronto.

The research builds on findings published last fall in Nature, which revealed that caspase-8 mutations are linked to immunodeficiency in humans. But the in vivo role of caspase-8 has remained uncertain until now, because deleting the molecule is lethal to embryos-making it impossible to fully understand what happens to cells without the molecule.

Researchers overcame this hurdle by targeting and eliminating caspase-8 from specific organ tissues in mice, enabling them to see how these tissues are affected by the absence of caspase-8.

"The research we've done has created a unique model that we and other scientists can use to further study the role of caspase-8 in the immune response," reports AMDI resear
'"/>

Contact: Kim Garwood
kim.garwood@uhn.on.ca
416-340-4800 Ext. 6753
University of Toronto
31-Mar-2003


Page: 1 2

Related biology news :

1. Immune systems attack dogs kept on genetic leash
2. Immune system drug may increase availability of liver transplants
3. Immune cells may help deliver cancer vaccines for children
4. Applied Biosystems and Immune Tolerance Network announce immunology research agreement
5. Immune system component found common to both humans and worms
6. Immune cells SLAP internal signals together
7. Immune co-stimulation and the Kaposis virus
8. Immune system helps prevent tumors after all
9. Even the Immune System works with Pincers
10. Immune system chemical may predict worsening of coronary heart disease in women
11. UWs new Cell Systems Initiative welcomes Immunex collaboration

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... ... in the global health and medical technology market, announced that it has selected ... / Robotics Solution” award in the 2019 MedTech Breakthrough Awards program. , ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, ... financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. ... platform that provides services to more than one dozen hospitals and surgery centers ...
(Date:6/4/2019)... ... June 04, 2019 , ... ... the appointment of Susan Murphy as the new President of Molecular Devices, replacing ... Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in a ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc ... application to the FDA for use of a person’s own adipose-derived stem cells to ... osteoarthritis in the knee. This IND is the first of several planned clinical ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for ... will educate viewers about how its technology facilitates laboratories to improve efficiency and ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative Medicine company, ... , has announced that their GMP facility for cell production is now approved ... This is an important milestone for VetStem as it expands into contract ...
(Date:5/31/2019)... (PRWEB) , ... May 29, 2019 , ... For many ... the toughest forms of cancer demand breakthrough therapies. Advances in immuno-oncology have led to ... patient’s own T cells with engineered T cell receptors known as “CARs”. The CAR ...
Breaking Biology Technology:
Cached News: